乙盐酸通过涉及转化生长因子-β的作用来抑制细胞增殖
Santiago Redondo1, Carlos G Santos-Gallego, Patricia Ganado
1Department of Pharmacology, School of Medicine, Universidad Complutense, CIEMAT, Madrid, Spain.
Circulation
|February 5, 2003
概括
乙盐酸 (ASA) 抑制了血管光滑肌肉细胞的增殖,可能通过转化增长因子-β (TGF-β) 来实现. 这种ASA-TGF-β链接表明,通过抑制血小板聚合和斑块生长来预防冠心病的双重机制.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 已知乙盐酸 (ASA) 抑制细胞增殖.
- 转化生长因子-β (TGF-β) 也抑制细胞增殖,并抑制细胞在G(0) 阶段.
- ASA的细胞效应与TGF-β的细胞效应类似.
研究的目的:
- 研究TGF-β在ASA介导的血管光滑肌肉细胞增殖抑制中的作用.
- 在心血管疾病预防的背景下证明ASA和TGF-β之间的联系.
主要方法:
- 培养的老鼠胸部大动脉血管光滑肌肉细胞.
- 评估了细胞毒性,细胞增殖,细胞周期以及TGF-β1转录和度.
- 利用抗TGF-β1来评估其在逆转ASA影响中的作用.
主要成果:
- 剂量依赖的ASA抑制了30.86%的细胞增殖,没有细胞毒性,抑制了G(0) 中的细胞.
- 抗TGF-β1逆转了这一抑制的30.21%.
- ASA降低了TGF-β1转录,但并没有显著改变其在超级生物中的度.
结论:
- TGF-β在ASA对血管光滑肌肉细胞的抗增殖作用中发挥着重要作用.
- 通过抗血小板作用和通过TGF-β抑制斑块生长,ASA可以预防冠心病.
- 这种机制也可以解释ASA在癌症化学预防,免疫调节和伤口愈合方面的作用.
更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:13Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
相关概念视频
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
